Patent directory · USPTO A61K / A61P
Patents matching “VANDA PHARMACEUTICALS INC.”
96 pharma patents match "VANDA PHARMACEUTICALS INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 96 pharmaceutical patents matching "VANDA PHARMACEUTICALS INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12427132
Method of improving sleep
granted -
US 12419869
Methods of treating multiple sclerosis
granted -
US 12409167
Pharmaceutical combination comprising a selective S1P1 receptor agonist
granted -
US 12403134
Method for improving or enhancing cognition
granted -
US 12357616
Methods of treating multiple sclerosis
granted -
US 12336980
Dosing regimen for a selective S1P1 receptor agonist
granted -
US 12318375
Method of treatment with tradipitant
granted -
US 12201604
Treatment of circadian rhythm disorders
granted -
US 12049457
Highly purified pharmaceutical grade tasimelteon
granted -
US 11951097
Methods of treating multiple sclerosis
granted -
US 11918557
Treatment of circadian rhythm disorders
granted -
US 11918556
Treatment of circadian rhythm disorders
granted -
US 11850229
Treatment of circadian rhythm disorders
granted -
US 11845990
Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
granted -
US 11833130
Treatment of circadian rhythm disorders
granted -
US 11826339
Treatment of circadian rhythm disorders
granted -
US 11786502
Method of treatment
granted -
US 11759446
Liquid tasimelteon formulations and methods of use thereof
granted -
US 11760740
Highly purified pharmaceutical grade tasimelteon
granted -
US 11737993
Multiple myeloma treatment
granted -
US 11723903
Treatment of schizophrenia
granted -
US 11667718
Cancer treatment
granted -
US 11633377
Treatment of circadian rhythm disorders
granted -
US 11607408
Method of treatment of schizophrenia
granted